PKPD model for lesinurad (Zurampic)
Indication: Hyperuricemia associated with gout
Semi-mechanistic uric acid simulator covering xanthine oxidase inhibition and uricosuric therapy for gout-related hyperuricemia. Designed to explore serum urate lowering across renal function scenarios.
Drug Overview
Clinical Context
- Molecular Target
- Xanthine oxidase and renal urate transport pathways
- Drug Class
- Xanthine Oxidase Inhibitors / Uricosurics
- Therapeutic Area
- Rheumatology
- Indication
- Hyperuricemia associated with gout
- Route of Administration
- Oral
Model Information
- Model Type
- Semi-mechanistic PK/PD
This simulator was built from published pharmacometric literature using PKPDBuilder's AI-powered model extraction pipeline.
About This Simulator
This interactive pharmacokinetic simulator for PKPD model for lesinurad (Zurampic) allows you to explore concentration-time profiles under different dosing scenarios. The underlying Semi-mechanistic PK/PD model characterizes the pharmacokinetics of this xanthine oxidase inhibitors / uricosurics following oral administration.
Use the simulator to visualize key exposure metrics including AUC (area under the curve), Cmax (peak concentration), and Ctrough (trough concentration). The pharmacodynamic component links drug exposure to therapeutic or safety endpoints.
Built with PKPDBuilder — an AI-powered platform that transforms published pharmacometric literature into interactive, deployable Shiny applications. No coding required.
Frequently Asked Questions
What is the PKPD model for lesinurad (Zurampic) PK simulator?
This is a free, interactive pharmacokinetic simulator for PKPD model for lesinurad (Zurampic) used in Hyperuricemia associated with gout. It allows researchers, pharmacologists, and students to explore concentration-time profiles, dosing regimens, and exposure metrics based on published population PK models.
What drug class does PKPD model for lesinurad (Zurampic) belong to?
PKPD model for lesinurad (Zurampic) is classified as a Xanthine Oxidase Inhibitors / Uricosurics that targets Xanthine oxidase and renal urate transport pathways. It is used in the Rheumatology therapeutic area.
What route of administration does this model simulate?
This simulator models Oral administration of PKPD model for lesinurad (Zurampic). The pharmacokinetic parameters (absorption rate, bioavailability, volume of distribution) are specific to this route.
What type of PK model is used?
This simulator uses a Semi-mechanistic PK/PD model. PK/PD models link drug concentrations to pharmacological effects, allowing exploration of exposure-response relationships.
Is this simulator free to use?
Yes, all PKPDBuilder simulators are completely free. They are built from published pharmacokinetic literature and are intended for research and educational purposes. No login is required to run simulations.
Can I use this for clinical dosing decisions?
No. This simulator is for research and educational purposes only. It should not be used for clinical decision-making or patient dosing. Always consult the prescribing information and clinical pharmacology guidelines for therapeutic drug use.
Ready to Simulate?
Launch the PKPD model for lesinurad (Zurampic) simulator to explore dosing scenarios and pharmacokinetic profiles interactively.
🚀 Launch SimulatorComments
⚠️ Disclaimer
This simulator is for research and educational purposes only. It is not intended for clinical decision-making, patient dosing, or therapeutic drug monitoring. Pharmacokinetic parameters are derived from published literature and represent population-level estimates. Individual patient pharmacokinetics may differ significantly. Always consult approved prescribing information and qualified healthcare professionals for clinical decisions.
Powered by PKPDBuilder.com • Free pharmacokinetic simulators for the scientific community